151 related articles for article (PubMed ID: 23979265)
1. Pentraxin 3 is a local inflammatory marker in atrial fibrillation.
Soeki T; Bando S; Uematsu E; Matsuura T; Niki T; Ise T; Kusunose K; Hotchi J; Ueda Y; Tomita N; Yamaguchi K; Yagi S; Fukuda D; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
Heart Vessels; 2014 Sep; 29(5):653-8. PubMed ID: 23979265
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
Tancin Lambert A; Kong XY; Ratajczak-Tretel B; Atar D; Russell D; Skjelland M; Bjerkeli V; Skagen K; Coq M; Schordan E; Firat H; Halvorsen B; Aamodt AH
Cerebrovasc Dis Extra; 2020; 10(1):11-20. PubMed ID: 32028277
[TBL] [Abstract][Full Text] [Related]
3. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
[TBL] [Abstract][Full Text] [Related]
4. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
6. Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation.
Soeki T; Matsuura T; Bando S; Tobiume T; Uematsu E; Ise T; Kusunose K; Yamaguchi K; Yagi S; Fukuda D; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
J Cardiol; 2016 Dec; 68(6):472-477. PubMed ID: 26987792
[TBL] [Abstract][Full Text] [Related]
7. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
Kaireviciute D; Blann AD; Balakrishnan B; Lane DA; Patel JV; Uzdavinys G; Norkunas G; Kalinauskas G; Sirvydis V; Aidietis A; Lip GY
Thromb Haemost; 2010 Jul; 104(1):122-7. PubMed ID: 20458440
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
[TBL] [Abstract][Full Text] [Related]
9. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis.
Fujita Y; Ito H; Sekino S; Numabe Y
Odontology; 2012 Jul; 100(2):215-21. PubMed ID: 21932007
[TBL] [Abstract][Full Text] [Related]
10. Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.
Hudzik B; Szkodzinski J; Pietka-Rzycka A; Danikiewicz A; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
J Interferon Cytokine Res; 2013 May; 33(5):280-4. PubMed ID: 23414296
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of immune cells across atrial endocardium in human atrial fibrillation.
Yamashita T; Sekiguchi A; Iwasaki YK; Date T; Sagara K; Tanabe H; Suma H; Sawada H; Aizawa T
Circ J; 2010 Feb; 74(2):262-70. PubMed ID: 20009387
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
[TBL] [Abstract][Full Text] [Related]
13. Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients.
Li JY; He Y; Ke HH; Jin Y; Jiang ZY; Zhong GQ
Clin Cardiol; 2017 Feb; 40(2):89-94. PubMed ID: 28207162
[TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Stress and Inflammatory Markers PTX3, CypA, and HB-EGF: How Are They Linked in Patients With STEMI?
Dejanović VV; Stevuljević JK; Vukašinović A; Miljković M; Kafedzic S; Zdravković M; Ilić I; Hinić S; Cerović M; Stefanović M; Spasojević-Kalimanovska V; Memon L; Nešković AN; Bogavac-Stanojević N
Angiology; 2020 Sep; 71(8):713-720. PubMed ID: 32372694
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability.
Shindo A; Tanemura H; Yata K; Hamada K; Shibata M; Umeda Y; Asakura F; Toma N; Sakaida H; Fujisawa T; Taki W; Tomimoto H
PLoS One; 2014; 9(6):e100045. PubMed ID: 24936646
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin 3 and other inflammatory biomarkers related to atrial fibrillation in cardiac surgery.
Holubcova Z; Kunes P; Mandak J; Vlaskova D; Kolackova M; Holmannova D; Andrys C; Krejsek J; Holubec T
Perfusion; 2017 May; 32(4):269-278. PubMed ID: 27852958
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation.
Watanabe T; Takeishi Y; Hirono O; Itoh M; Matsui M; Nakamura K; Tamada Y; Kubota I
Heart Vessels; 2005 Mar; 20(2):45-9. PubMed ID: 15772777
[TBL] [Abstract][Full Text] [Related]
19. Endocardial contact mapping of the left atrial appendage in persistent atrial fibrillation.
Takahashi Y; Akiyoshi K; Sekigawa M; Yagishita A; Yamamoto T; Maeda S; Kawabata M; Goya M; Hirao K; Sasano T
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):112-118. PubMed ID: 31724790
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation.
Henningsen KM; Nilsson B; Bruunsgaard H; Chen X; Pedersen BK; Svendsen JH
Scand Cardiovasc J; 2009; 43(5):285-91. PubMed ID: 19117239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
